IMF Videos Search Content For Healthcare Professional (122) Healthcare Provider (122) Care Partner (75) Patient (74) Series - Any - ASCO/EHA (49) ASH (60) Ask Dr. Durie (16) Black Swan Research Initiative (5) Community Workshops (4) Emerging Therapies (6) Facebook Live (10) Health Equity (2) IMWG (3) Inspirational (3) Living Well with Myeloma (4) Myeloma in a Minute (1) Myeloma Made Simple (3) Patient & Family Webinar (4) Q&A (7) Recent News and Developments (4) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (65) High-Risk Myeloma (42) High-risk Smoldering Myeloma (34) Late Relapse (4–6 Lines of Therapy) (81) MGUS (35) Newly Diagnosed (Pre-Treatment or First Treatment) (64) Smoldering Myeloma (50) Types of Therapy Immunomodulatory drugs (IMiDs) (58) Immunotherapies (CAR T; BiTE, etc.) (93) Monoclonal antibodies (48) Proteasome inhibitors (43) Stem cell transplant (40) Steroids (41) Supportive Care (36) Year Published 2026 (16) 2025 (38) 2024 (58) 2023 (39) 2022 (10) 2021 (7) 2020 (1) 2019 (9) 2018 (2) 2017 (1) 2016 (3) Trusted Voices Dr. Joseph Mikhael (36) Dr. Brian GM Durie (15) Dr. María-Victoria Mateos (6) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (5) Dr. Saad Usmani (3) Dr. Sigurður Kristinsson (3) Dr. Shaji Kumar (2) Dr. Urvi A. Shah (2) Dr. Sagar Lonial (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Understanding Clinical Trials in Myeloma: Phases, Benefits, Risks & Patient Access September 10, 2025 Patient & Family Webinar Patient Empowerment in Multiple Myeloma: Shared Decision-Making, Clinical Trials & Better Care in 2025 September 9, 2025 Patient & Family Webinar Hot Topics in Multiple Myeloma 2025: New Drug Approvals, MRD, and the Path to a Cure September 9, 2025 Patient & Family Webinar "33% of Late Relapse Myeloma Patients Disease-Free at 5 Years?” | ASCO & EHA Breakthroughs 2025 August 14, 2025 ASCO/EHA Key Abstracts Presented at ASCO and EHA 2025 August 1, 2025 ASCO/EHA Newly Diagnosed Multiple Myeloma: What’s Changing in 2025? | ASCO & EHA July 31, 2025 ASCO/EHA IMF Virtual Myeloma Community Workshop (MCW): What’s Next? – Managing Myeloma at Relapse July 29, 2025 Community Workshops Linvoseltamab+Carfilzomib in Relapsed/Refractory Multiple Myeloma: LINKER-MM2 Trial Initial Results July 25, 2025 ASCO/EHA KRd with or without daratumumab in newly diagnosed multiple myeloma: ADVANCE trial results July 24, 2025 ASCO/EHA Multiple Myeloma Clinical Trials Explained & QA | Expert Advice & Real Patient Stories July 24, 2025 Facebook Live SC daratumumab + VRd with DR maintenance in TE NDMM: sustained MRD negativity in PERSEUS trial July 23, 2025 ASCO/EHA Subcutaneous vs IV isatuximab + pomalidomide/dexamethasone in R/R MM: IRAKLIA phase 3 study July 21, 2025 ASCO/EHA Load More
